1. Home
  2. TNET vs HRMY Comparison

TNET vs HRMY Comparison

Compare TNET & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$47.58

Market Cap

1.7B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$34.43

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
HRMY
Founded
1988
2017
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
TNET
HRMY
Price
$47.58
$34.43
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$65.80
$44.11
AVG Volume (30 Days)
360.2K
709.3K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.57%
N/A
EPS Growth
N/A
7.97
EPS
1.90
0.55
Revenue
$5,010,000,000.00
$868,453,000.00
Revenue This Year
N/A
$19.75
Revenue Next Year
$3.30
$12.88
P/E Ratio
$25.17
$64.00
Revenue Growth
N/A
21.51
52 Week Low
$33.67
$25.52
52 Week High
$77.61
$40.87

Technical Indicators

Market Signals
Indicator
TNET
HRMY
Relative Strength Index (RSI) 63.42 62.32
Support Level $34.47 $25.92
Resistance Level $49.50 $34.99
Average True Range (ATR) 1.94 1.10
MACD 0.13 0.39
Stochastic Oscillator 78.87 75.30

Price Performance

Historical Comparison
TNET
HRMY

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: